BN Business News
Aggiungi la tua azienda →
Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.

Imprese · 23/10/20131 min di lettura

Determination That Potassium Citrate, 10 Milliequivalents/Packet and 20 Milliequivalents/Packet, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

Traduzione automatica locale · Lingua originale della fonte

Riepilogo

The Food and Drug Administration (FDA) has determined that Potassium Citrate, 10 milliequivalents/packet (mEq/packet) and 20 mEq/ packet, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for Potassium Citrate, 10 mEq/packet and 20 mEq/packet, if all other legal and regulatory requirements are met.

Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →

Esplora gli approfondimenti

Analisi aziendali →